Universidad de Santander Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00428727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Universidad de Santander, Bucaramanga, Colombia (National Sponsor in Colombia)